Sucralfate 100 MG/ML Oral Suspension — RxCUI 313123
RxNorm drug concept · Semantic clinical drug
RxCUI 313123
Semantic clinical drug · SCD
● Current RxNorm concept 23 FDA products
42 package NDCs
Snapshot Jul 14, 2026
What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.
🗂️ Key Facts
RxCUI313123
Official nameSucralfate 100 MG/ML Oral Suspension
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known assucralfate 1 GM per 10 ML Oral Suspension; sucralfate 1 GM in 10 mL Oral Suspension
FDA products mapped23
Package NDCs mapped42
Reported Medicaid activity (SDUD)164,777 prescriptions · 51 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026
📖 Skip the Codes — Read It in Plain English.
Our pharmacist-built guide to Sucralfate: what it is, how it’s used, side effects, and interactions.
📗 Our plain-language guide HelloPharmacist
- It treats an active duodenal ulcer, which is a sore in the first part of your small intestine. Treatment usually lasts up to 8 weeks. The tablets can also be used at a lower dose t...
- Take it by mouth on an empty stomach, as your prescriber directs. For an active ulcer, the label describes four doses a day. Keep going for the full course even if you feel better,...
- Yes, for pain relief if your doctor allows. Just keep them at least 30 minutes before or after your sucralfate dose.
- Constipation is the most common one, though most people have no trouble. Some get nausea, diarrhea, dry mouth, dizziness or a rash. Call your doctor if something bothers you or doe...
🕸️ Concept Web — How Sucralfate 100 MG/ML Oral Suspension Connects
One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept
Sucralfate 100 MG/ML Oral Suspension
RxCUI 313123 Semantic clinical drug · SCD
Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.
-
Ingredients 1
The active substance itself — no strength, form, or brand attached yet.
-
Sucralfate
10156IN
-
Sucralfate
-
Brand names 1
The same medicine's trade names. A brand name alone says nothing about strength or form.
-
Carafate
227743BN
-
Carafate
-
Dose forms 9
The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
-
Sucralfate Oral Suspension
373966SCDF -
Sucralfate Oral Liquid Product
1161767SCDG -
Sucralfate Oral Product
1161768SCDG -
Sucralfate Oral Suspension [Carafate]
365868SBDF -
Carafate Oral Liquid Product
1173681SBDG -
Carafate Oral Product
1173682SBDG -
Oral Suspension
316969DF -
Oral Liquid Product
1151137DFG - +1 more in this family
-
Sucralfate Oral Suspension
-
Clinical & branded drugs 3
Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
-
Sucralfate 100 MG/ML
316737SCDC -
Sucralfate 100 MG/ML Oral Suspension [Carafate]
208094SBD -
Sucralfate 100 MG/ML [Carafate]
568822SBDC
-
Sucralfate 100 MG/ML
Showing up to 8 concepts per family — 13 of 14 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.
🔀 Generic ⇄ Brand Crosswalk
The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.
Generic (Clinical) Concepts
-
Sucralfate 100 MG/ML
SCDC · 316737 -
Sucralfate Oral Suspension
SCDF · 373966 -
Sucralfate Oral Liquid Product
SCDG · 1161767 -
Sucralfate Oral Product
SCDG · 1161768
Brand-Name Concepts
-
Sucralfate 100 MG/ML Oral Suspension [Carafate]
SBD · 208094 -
Sucralfate 100 MG/ML [Carafate]
SBDC · 568822 -
Sucralfate Oral Suspension [Carafate]
SBDF · 365868 -
Carafate Oral Liquid Product
SBDG · 1173681 -
Carafate Oral Product
SBDG · 1173682 -
Carafate
BN · 227743
📦 FDA Products & Package NDCs
23 products · 42 package NDCs
42 package NDCs map to RxCUI 313123 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
| Package NDC | Package | Brand / generic name | Labeler | Marketing start |
|---|---|---|---|---|
| 00121-0974-00 | 10 TRAY in 1 TRAY (0121-0974-00) / 10 CUP, UNIT-DOSE in 1 T... | Sucralfate | PAI Holdings, LLC dba PAI Pharma | 2022-08-31 |
| 00121-0974-40 | 4 TRAY in 1 CASE (0121-0974-40) / 10 CUP, UNIT-DOSE in 1 TR... | Sucralfate | PAI Holdings, LLC dba PAI Pharma | 2022-08-31 |
| 00121-0974-50 | 5 PACKAGE in 1 TRAY (0121-0974-50) / 10 CUP, UNIT-DOSE in 1... | Sucralfate | PAI Holdings, LLC dba PAI Pharma | 2022-08-31 |
| 00121-0974-94 | 3 TRAY in 1 CASE (0121-0974-94) / 10 CUP, UNIT-DOSE in 1 TR... | Sucralfate | PAI Holdings, LLC dba PAI Pharma | 2022-08-31 |
| 00378-9205-35 | 420 mL in 1 BOTTLE, PLASTIC (0378-9205-35) | sucralfate | Mylan Pharmaceuticals Inc. | 2022-09-22 |
| 00713-0791-75 | 420 mL in 1 BOTTLE (0713-0791-75) | Sucralfate | Cosette Pharmaceuticals, Inc. | 2024-12-19 |
| 00904-7470-01 | 30 CUP, UNIT-DOSE in 1 CASE (0904-7470-01) / 10 mL in 1 CUP... | Sucralfate | Major Pharmaceuticals | 2024-06-26 |
| 00904-7470-18 | 40 CUP, UNIT-DOSE in 1 CASE (0904-7470-18) / 10 mL in 1 CUP... | Sucralfate | Major Pharmaceuticals | 2024-06-26 |
| 00904-7470-56 | 20 CUP, UNIT-DOSE in 1 CASE (0904-7470-56) / 10 mL in 1 CUP... | Sucralfate | Major Pharmaceuticals | 2024-06-26 |
| 00904-7470-66 | 10 mL in 1 CUP, UNIT-DOSE (0904-7470-66) | Sucralfate | Major Pharmaceuticals | 2024-06-26 |
| 00904-7470-72 | 100 CUP, UNIT-DOSE in 1 CASE (0904-7470-72) / 10 mL in 1 CU... | Sucralfate | Major Pharmaceuticals | 2024-06-26 |
| 00904-7470-95 | 50 CUP, UNIT-DOSE in 1 CASE (0904-7470-95) / 10 mL in 1 CUP... | Sucralfate | Major Pharmaceuticals | 2024-06-26 |
| 13668-0754-42 | 420 mL in 1 BOTTLE (13668-754-42) | Sucralfate | Torrent Pharmaceuticals Limited | 2025-09-15 |
| 17856-0306-01 | 72 CUP, UNIT-DOSE in 1 BOX, UNIT-DOSE (17856-0306-1) / 10 m... | Sucralfate | ATLANTIC BIOLOGICALS CORP. | 2023-08-10 |
| 42291-0781-42 | 420 mL in 1 BOTTLE (42291-781-42) | Sucralfate | AvKARE | 2021-04-16 |
| 50268-0745-14 | 40 CUP in 1 BOX (50268-745-14) / 10 mL in 1 CUP (50268-745-... | Sucralfate | AvPAK | 2022-08-31 |
| 50742-0386-42 | 420 mL in 1 BOTTLE (50742-386-42) | Sucralfate | Ingenus Pharmaceuticals, LLC | 2024-11-21 |
| 52817-0840-16 | 473 mL in 1 BOTTLE (52817-840-16) | Sucralfate | TruPharma, LLC | 2024-04-01 |
| 54738-0005-42 | 420 mL in 1 BOTTLE (54738-005-42) | Sucralfate | Richmond Pharmaceuticals, Inc. | 2025-05-22 |
| 55154-4348-05 | 5 CUP in 1 BAG (55154-4348-5) / 10 mL in 1 CUP | Sucralfate | Cardinal Health 107, LLC | 2024-10-31 |
| 55154-5790-05 | 5 CUP, UNIT-DOSE in 1 BAG (55154-5790-5) / 10 mL in 1 CUP,... | Sucralfate | Cardinal Health 107, LLC | 2022-03-15 |
| 58914-0170-14 | 420 mL in 1 BOTTLE (58914-170-14) | Carafate | Allergan, Inc. | 1993-12-16 |
| 58914-0170-60 | 6 CUP, UNIT-DOSE in 1 BOX (58914-170-60) / 10 mL in 1 CUP,... | Carafate | Allergan, Inc. | 1993-12-16 |
| 60687-0738-08 | 3 TRAY in 1 CASE (60687-738-08) / 10 CUP, UNIT-DOSE in 1 TR... | Sucralfate | American Health Packaging | 2023-08-01 |
| 60687-0738-23 | 4 TRAY in 1 CASE (60687-738-23) / 10 CUP, UNIT-DOSE in 1 TR... | Sucralfate | American Health Packaging | 2023-08-01 |
| 60687-0738-56 | 10 TRAY in 1 CASE (60687-738-56) / 10 CUP, UNIT-DOSE in 1 T... | Sucralfate | American Health Packaging | 2023-08-01 |
| 64380-0149-01 | 420 mL in 1 BOTTLE, PLASTIC (64380-149-01) | sucralfate | Strides Pharma Science Limited | 2024-07-10 |
| 64380-0149-03 | 5 CUP, UNIT-DOSE in 1 TRAY (64380-149-03) / 10 mL in 1 CUP,... | sucralfate | Strides Pharma Science Limited | 2024-07-10 |
| 64380-0149-04 | 3 TRAY in 1 CARTON (64380-149-04) / 10 CUP, UNIT-DOSE in 1... | sucralfate | Strides Pharma Science Limited | 2024-07-10 |
| 64380-0149-05 | 4 TRAY in 1 CARTON (64380-149-05) / 10 CUP, UNIT-DOSE in 1... | sucralfate | Strides Pharma Science Limited | 2024-07-10 |
| 64380-0149-06 | 5 TRAY in 1 CARTON (64380-149-06) / 10 CUP, UNIT-DOSE in 1... | sucralfate | Strides Pharma Science Limited | 2024-07-10 |
| 64380-0149-07 | 10 TRAY in 1 CARTON (64380-149-07) / 10 CUP, UNIT-DOSE in 1... | sucralfate | Strides Pharma Science Limited | 2024-07-10 |
| 65162-0062-05 | 420 mL in 1 BOTTLE (65162-062-05) | Sucralfate | Amneal Pharmaceuticals LLC | 2019-12-02 |
| 65162-0062-48 | 10 CUP, UNIT-DOSE in 1 TRAY (65162-062-48) / 10 mL in 1 CUP... | Sucralfate | Amneal Pharmaceuticals LLC | 2019-12-02 |
| 66689-0305-16 | 1 BOTTLE, PLASTIC in 1 CARTON (66689-305-16) / 414 mL in 1... | Sucralfate | VistaPharm, LLC | 2022-03-15 |
| 68094-0041-61 | 10 TRAY in 1 CASE (68094-041-61) / 10 CUP, UNIT-DOSE in 1 T... | Sucralfate | Precision Dose, Inc. | 2025-01-30 |
| 68094-0041-62 | 3 TRAY in 1 CASE (68094-041-62) / 10 CUP, UNIT-DOSE in 1 TR... | Sucralfate | Precision Dose, Inc. | 2025-01-30 |
| 68462-0827-61 | 420 mL in 1 BOTTLE (68462-827-61) | Sucralfate oral suspension | Glenmark Pharmaceuticals Inc., USA | 2026-01-05 |
| 72162-2479-02 | 420 mL in 1 BOTTLE (72162-2479-2) | sucralfate | Bryant Ranch Prepack | 2025-05-01 |
| 81033-0149-44 | 40 CUP, UNIT-DOSE in 1 CARTON (81033-149-44) / 10 mL in 1 C... | Sucralfate | Kesin Pharma Corporation | 2024-07-01 |
| 81033-0149-52 | 100 CUP, UNIT-DOSE in 1 CASE (81033-149-52) / 10 mL in 1 CU... | Sucralfate | Kesin Pharma Corporation | 2024-07-01 |
| 82182-0106-14 | 420 mL in 1 BOTTLE (82182-106-14) | Sucralfate | Pacific Pharma, Inc. | 2024-02-01 |
Observed labelers:
Major Pharmaceuticals (6) ·
Strides Pharma Science Limited (6) ·
PAI Holdings, LLC dba PAI Pharma (4) ·
American Health Packaging (3) ·
Allergan, Inc. (2) ·
Amneal Pharmaceuticals LLC (2)
· +16 more — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.
💲 Pricing (NADAC)
NADAC is CMS's National Average Drug Acquisition Cost — roughly what pharmacies pay to buy the drug. It is an acquisition benchmark, not your copay.
Per ml · median
$0.1174
Range $0.1144–$0.1174
· middle 50% $0.1174–$0.1174
· 9 NDCs
Latest compatible distributions from the CMS NADAC file · dataset watermark 2026-07-10. Prices vary by package and pharmacy; a distribution is shown instead of one misleading number. Rows the dataset is silent on carry no price. No zero-cost conclusion should be drawn.
🗃️ Sources & Limits
Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
- A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
- Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
- Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
- Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.
Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.